MENU
BR | BRL
BR | BRL
-
- Todas as centrífugas
- Centrífugas de bancada
- Centrífugas de chão
- Centrífugas refrigeradas
- Microcentrífugas
- Centrífugas multifuncionais
- Centrífugas de alta velocidade
- Ultracentrífugas
- Concentrador
- Consumíveis de alta velocidade e de ultracentrifugação
- Tubos de centrifugação
- Placas de centrifugação
- Software de gestão de equipamentos
- Gestão de amostras e informações
-
- Todas as pipetas, dispensadores e equipamentos para manuseio de líquidos automatizados
- Pipetas mecânicas
- Pipetas eletrônicas
- Pipetas multicanal
- Pipetas de deslocamento positivo e dispensadores
- Ponteiras de pipeta
- Dispensadores de frascos
- Controladores de pipeta
- Acessórios para dispensadores e pipetas
- Pipetagem Automatizada
- Consumíveis de automação
- Acessórios de automação
- Serviços para pipetas e equipamentos para manuseio de líquidos
Sorry, we couldn't find anything on our website containing your search term.
Sorry, we couldn't find anything on our website containing your search term.
Vaccine Research Discovered
Well thought-out tools for pharmaceutical and biotech laboratories
Read more
Read less
THE MOST NOVEL VACCINES
Nucleic acid vaccines
Nucleic acid vaccines are made up of mRNA or plasmid DNA encoding viral antigenic components to express specific proteins of a pathogen after injection. The technology of mRNA vaccines made its breakthrough with SARS-CoV-2. With dozens of new applications including HIV, cancer, shingles, flu, cardiovascular applications, or Zika, it is a very promising technology.
Nucleic acid vaccines are made up of mRNA or plasmid DNA encoding viral antigenic components to express specific proteins of a pathogen after injection. The technology of mRNA vaccines made its breakthrough with SARS-CoV-2. With dozens of new applications including HIV, cancer, shingles, flu, cardiovascular applications, or Zika, it is a very promising technology.
Ler mais
➕ Multiple advantages such as exceptionally fast modifiability in response to mutations, high versatility, high safety, and a fast, cost-efficient, and scalable production in a cell-free system. Vaccines for multiple indications can be produced using the same process.
➖ During vaccination the mRNA must be delivered directly into cells, which requires specific injection devices, electroporation, or a carrier molecule. mRNA vaccines exhibit instability and require a cold chain
➖ During vaccination the mRNA must be delivered directly into cells, which requires specific injection devices, electroporation, or a carrier molecule. mRNA vaccines exhibit instability and require a cold chain
Ler mais
BETTER MRNA VACCINE DEVELOPMENT
Ler mais
*All products are for Research Use Only (RUO).
Ler mais
DOWNLOADS
Application Note
Application Note
White Paper
White Paper
Application Note
Ler mais